A small biotech out of Australia called Prana Biotechnology Ltd. (NASDAQ: PRAN) today is trading up nearly 50% to a new 52-week high on favorable results in Alzheimer's Disease studies. ... Read Full Story »
Everyone knows about the current and future epidemic of Alzheimer's Disease. This disease is largely untreated and most current treatments gear around early diagnosis, slowing the onset, or prolonging the ... Read Full Story »
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) has announced that dosing has commenced in its Phase IIa clinical trial with LX6171. This is an oral drug candidate that is implied for the ... Read Full Story »
ICAgen's (ICGN-NASDAQ) stock is being crushed in after-hours trading, although the trading volume is very light. Shares are down 37% to $1.15 after closing down 2.6% today. Read on, because ... Read Full Story »